These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22896003)

  • 1. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
    Allen JL; Fore MS; Wooten J; Roehrs PA; Bhuiya NS; Hoffert T; Sharf A; Deal AM; Armistead P; Coghill J; Gabriel DA; Irons R; Essenmacher A; Shea TC; Richards K; Cutler C; Ritz J; Serody J; Baldwin AS; Sarantopoulos S
    Blood; 2012 Sep; 120(12):2529-36. PubMed ID: 22896003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
    Jacobson CA; Sun L; Kim HT; McDonough SM; Reynolds CG; Schowalter M; Koreth J; Cutler CS; Ho VT; Alyea EP; Armand P; Blazar BR; Soiffer RJ; Antin JH; Ritz J; Sarantopoulos S
    Biol Blood Marrow Transplant; 2014 May; 20(5):668-75. PubMed ID: 24462743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
    Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
    Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
    Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
    Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Washel WS; Bhuiya NS; Cutler CS; Alyea EP; Ho VT; Soiffer RJ; Antin JH; Ritz J
    Blood; 2011 Feb; 117(7):2275-83. PubMed ID: 21097674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased BCR responsiveness in B cells from patients with chronic GVHD.
    Allen JL; Tata PV; Fore MS; Wooten J; Rudra S; Deal AM; Sharf A; Hoffert T; Roehrs PA; Shea TC; Serody JS; Richards KL; Jagasia M; Lee SJ; Rizzieri D; Horwitz ME; Chao NJ; Sarantopoulos S
    Blood; 2014 Mar; 123(13):2108-15. PubMed ID: 24532806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cells in chronic graft-versus-host disease.
    McManigle W; Youssef A; Sarantopoulos S
    Hum Immunol; 2019 Jun; 80(6):393-399. PubMed ID: 30849450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cells in chronic graft-versus-host disease.
    Sarantopoulos S; Blazar BR; Cutler C; Ritz J
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):16-23. PubMed ID: 25452031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Bhuiya NS; Cutler CS; Soiffer RJ; Antin JH; Ritz J
    Clin Cancer Res; 2007 Oct; 13(20):6107-14. PubMed ID: 17947475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-Negative T Cell Levels Correlate with Chronic Graft-versus-Host Disease Severity.
    Hillhouse EE; Thiant S; Moutuou MM; Lombard-Vadnais F; Parat R; Delisle JS; Ahmad I; Roy DC; Guimond M; Roy J; Lesage S
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):19-25. PubMed ID: 30244108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
    Poe JC; Jia W; Su H; Anand S; Rose JJ; Tata PV; Suthers AN; Jones CD; Kuan PF; Vincent BG; Serody JS; Horwitz ME; Ho VT; Pavletic SZ; Hakim FT; Owzar K; Zhang D; Blazar BR; Siebel CW; Chao NJ; Maillard I; Sarantopoulos S
    Blood; 2017 Nov; 130(19):2131-2145. PubMed ID: 28851699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
    Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
    Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing role of B cells in the pathogenesis and treatment of chronic GVHD.
    Li X; Gao Q; Feng Y; Zhang X
    Br J Haematol; 2019 Feb; 184(3):323-336. PubMed ID: 30585319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
    Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
    Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.
    Glauzy S; Soret J; Fournier I; Douay C; Moins-Teisserenc H; Peffault de Latour R; Maki G; Robin M; Socié G; Toubert A; Clave E
    Blood; 2014 Oct; 124(15):2459-62. PubMed ID: 25185266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.
    Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Snavely J; Chen H; Savani BN; Kassim A; Greer JP; Schuening FG; Engelhardt BG; Jagasia MH
    Blood; 2011 Jul; 118(4):1140-4. PubMed ID: 21628416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant B-cell homeostasis in chronic GVHD.
    Sarantopoulos S; Ritz J
    Blood; 2015 Mar; 125(11):1703-7. PubMed ID: 25645355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.
    Rozmus J; Kariminia A; Abdossamadi S; Storer BE; Martin PJ; Lee SJ; Wolff D; Arora M; Cutler C; Schultz KR
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):451-458. PubMed ID: 30447393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.